MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2174/1871523019999201111192344

Медицинская библиотека · Anti-inflammatory & anti-allergy agents in medicinal chemistry · 2021

In-silico Prediction of the Beta-carboline Alkaloids Harmine and Harmaline as Potent Drug Candidates for the Treatment of Parkinson's disease.

Banerjee Rumpa, Kumar Mukesh, Gaurav Isha, Thakur Sudha, Thakur Abhimanyu, Singh Kunal, Karak Sanchari, Das Rajeswar, Chhabra Mohit

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Parkinson's disease (PD) is a progressive neurodegenerative disease manifested by core symptoms of loss of motor control and postural instability. Loss of dopaminergic neurons is the cause of PD, thus enhancing dopamine level by pharmacological treatment is one of the key treatment strategies for PD. However, the limitations of current treatment strategies open the possibility of novel drug candidates for the treatment of PD.

OBJECTIVE

To investigate the anti-PD potential of Harmine and Harmaline. We aim to evaluate the therapeutic potential of Harmine and Harmaline by in-silico approaches; molecular docking, pharmacokinetic and Prediction of Activity Spectra for Substances (PASS) analysis were used for evaluating the therapeutic potential of Harmine and Harmaline and standard drug levodopa (L-DOPA).

METHODS

Auto dock vina was used for molecular docking of all three compounds against D2- and D3- dopamine receptors. The pharmacokinetics (PKs) and toxicity profile were predicted by pkCSM, and the pharmacological activity was predicted by PASS analysis.

RESULTS

Molecular docking showed a higher binding affinity of Harmine and Harmaline as compared to L-DOPA, and these results were supported by in-silico pharmacokinetic and toxicity profiling. Moreover, PASS analysis showed anti-PD activity of Harmine and Harmaline.

CONCLUSION

Harmine and Harmaline exhibit higher binding affinity towards D2- and D3- dopamine receptors compared to L-DOPA, and PKs and toxicity profile support their potential as drug candidates for PD therapy.

Для цитирования: Banerjee Rumpa, Kumar Mukesh, Gaurav Isha, Thakur Sudha, Thakur Abhimanyu, Singh Kunal, Karak Sanchari, Das Rajeswar, Chhabra Mohit. In-silico Prediction of the Beta-carboline Alkaloids Harmine and Harmaline as Potent Drug Candidates for the Treatment of Parkinson's disease.. Anti-inflammatory & anti-allergy agents in medicinal chemistry. 2021. DOI: 10.2174/1871523019999201111192344.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.